Extracellular vesicles released by transforming growth factor-beta 1-preconditional mesenchymal stem cells promote recovery in mice with spinal cord injury
Open Access
- 1 May 2024
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 35, 135-149
Abstract
Spinal cord injury (SCI) causes neuroinflammation, neuronal death, and severe axonal connections. Alleviating neuroinflammation, protecting residual cells and promoting neuronal regeneration via endogenous neural stem cells (eNSCs) represent potential strategies for SCI treatment. Extracellular vesicles (EVs) released by mesenchymal stem cells have emerged as pathological mediators and alternatives to cell-based therapies following SCI. In the present study, EVs isolated from untreated (control, C-EVs) and TGF-β1-treated (T-EVs) mesenchymal stem cells were injected into SCI mice to compare the therapeutic effects and explore the underlying mechanisms. Our study demonstrated for the first time that the application of T-EVs markedly enhanced the proliferation and antiapoptotic ability of NSCs in vitro. The infusion of T-EVs into SCI mice increased the shift from the M1 to M2 polarization of reactive microglia, alleviated neuroinflammation, and enhanced the neuroprotection of residual cells during the acute phase. Moreover, T-EVs increased the number of eNSCs around the epicenter. Consequently, T-EVs further promoted neurite outgrowth, increased axonal regrowth and remyelination, and facilitated locomotor recovery in the chronic stage. Furthermore, the use of T-EVs in Rictor−/− SCI mice (conditional knockout of Rictor in NSCs) showed that T-EVs failed to increase the activation of eNSCs and improve neurogenesis sufficiently, which suggested that T-EVs might induce the activation of eNSCs by targeting the mTORC2/Rictor pathway. Taken together, our findings indicate the prominent role of T-EVs in the treatment of SCI, and the therapeutic efficacy of T-EVs for SCI treatment might be optimized by enhancing the activation of eNSCs via the mTORC2/Rictor signaling pathway.Keywords
This publication has 75 references indexed in Scilit:
- PI3K‐p110‐alpha‐subtype signalling mediates survival, proliferation and neurogenesis of cortical progenitor cells via activation of mTORC2Journal of Neurochemistry, 2014
- Transforming Growth Factor-β1 Mediates Migration in Cultured Human Control and Exstrophy Bladder Smooth Muscle CellsJournal of Urology, 2012
- Long-Distance Growth and Connectivity of Neural Stem Cells after Severe Spinal Cord InjuryCell, 2012
- Reconstitution of the central and peripheral nervous system during salamander tail regenerationProceedings of the National Academy of Sciences, 2012
- mTOR complex 2 signaling and functionsCell Cycle, 2011
- MicroparticlesCirculation Research, 2010
- Transforming growth factor‐β1 regulates the fate of cultured spinal cord‐derived neural progenitor cellsCell Proliferation, 2008
- Degenerative and Spontaneous Regenerative Processes after Spinal Cord InjuryJournal of Neurotrauma, 2006
- Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult ratNeuroscience, 2005
- A Monitored Contusion Model of Spinal Cord Injury in the RatJournal of Neurotrauma, 1992